| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | Nov 21, 2025 | Natera, Inc. | Director | Sell | 27.5 | -12,780 | -6.97% | ✓ | $2.8M |
| Feb 6, 2025 | Feb 10, 2025 | Travere Therapeutics, Inc. | Director | Sell | 15.0 | -10,000 | -24.39% | ✓ | $220K |
| Jan 23, 2025 | Jan 23, 2025 | Travere Therapeutics, Inc. | Director | Sell | 7.5 | -16,000 | -34.04% | ✓ | $320K |
| Nov 15, 2024 | Nov 15, 2024 | Natera, Inc. | Director | Sell | 3.8 | -37,230 | -70.20% | ✓ | $5.4M |
| Aug 7, 2020 | Aug 11, 2020 | Natera, Inc. | Director | Sell | 22.5 | -1,300 | -100.00% | ✗ | $69.5K |